CStone Pharmaceuticals advances cancer research with first-in-human clinical trial application for CS2009

CStone Pharmaceuticals, an innovation-driven biopharmaceutical company listed on the Hong Kong Stock Exchange (HKEX: 2616), has taken a significant step forward in its mission to ... Read More